Dashboard
Manage Tickers

AMGN AMGEN INC

Nasdaq amgen.com


$ 298.00 $ 6.43 (2.2 %)    

Friday, 31-Oct-2025 18:17:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 298.43
$ 288.46
$ 297.00 x 1
$ 298.45 x 20
$ 288.00 - $ 298.88
$ 247.06 - $ 330.26
2,687,516
na
160.66B
$ 0.47
$ 24.27
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-14-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 04-28-2023 03-31-2023 10-Q
11 02-09-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 04-28-2022 03-31-2022 10-Q
15 02-16-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 04-28-2021 03-31-2021 10-Q
19 02-09-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 07-29-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-12-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-13-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 07-27-2018 06-30-2018 10-Q
30 04-25-2018 03-31-2018 10-Q
31 02-13-2018 12-31-2017 10-K
32 10-26-2017 09-30-2017 10-Q
33 07-26-2017 06-30-2017 10-Q
34 04-27-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 07-29-2016 06-30-2016 10-Q
38 05-02-2016 03-31-2016 10-Q
39 02-16-2016 12-31-2015 10-K
40 11-02-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

a-look-into-amgen-incs-price-over-earnings
A Look Into Amgen Inc's Price Over Earnings
10/31/2025 14:01:34

amgen-to-present-new-data-from-cardiovascular-portfolio-including-late-breaking-results-from-phase-3-vesalius-cv-clinical-trial-of-repatha-at-ahass-2025
Amgen To Present New Data From Cardiovascu...
10/31/2025 13:03:39

Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never ...

marjorie-taylor-greene-buys-netflix-stock-after-downbeat-q3-earnings-expands-big-tech-bet
Marjorie Taylor Greene Buys Netflix Stock ...
10/31/2025 07:08:12

MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and A...

Core News & Articles
Agilent Technologies Appoints Amgen Execut...
10/27/2025 20:21:17

Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective No...

what-does-the-market-think-about-amgen-inc
What Does the Market Think About Amgen Inc?
10/27/2025 20:00:47

biogens-immunology-pipeline-has-long-term-potential-analyst
Biogen's Immunology Pipeline Has Long-Term...
10/24/2025 16:47:04

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across mul...

Core News & Articles
Amgen Announces FDA Approval Of TEZSPIRE F...
10/17/2025 20:02:05

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation

price-over-earnings-overview-amgen
Price Over Earnings Overview: Amgen
10/17/2025 16:00:46

novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs
Novo Vs. Lilly Vs. Pfizer: Who Wins If Tru...
10/17/2025 14:19:58

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

marjorie-taylor-greene-cathie-wood-snap-up-the-same-13-stocks--heres-the-unlikely-portfolio-crossover
Marjorie Taylor Greene, Cathie Wood Snap U...
10/16/2025 21:29:48

A look at the stock owned by both Ark Funds and Congresswoman Marjorie Taylor Greene.

small-cap-biotech-climb-bios-lead-drug-candidate-has-larger-long-term-opportunity
Small-Cap Biotech Climb Bio's Lead Drug Ca...
10/16/2025 17:40:28

William Blair assigns Climb Bio an Outperform rating, projecting peak sales of $1.9 billion and long-term growth for its therap...

trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans
Trump Plans AstraZeneca Deal To Cut Drug P...
10/10/2025 18:48:27

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

trump-administration-engages-pharmacies-goodrx-for-trumprx-launch
Trump Administration Engages Pharmacies, G...
10/09/2025 19:09:34

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

amgen-to-offer-cholesterol-drug-at-60-discount-as-trump-administrations-call-to-lower-drug-prices
Amgen To Offer Cholesterol Drug At 60% Dis...
10/06/2025 18:27:22

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrict...

Core News & Articles
GoodRx And Amgen Partner To Offer Repatha ...
10/06/2025 13:16:21

The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innovative cholesterol-lowering ...

amgen-launches-amgennow-program-offering-repatha-direct-to-patients-at-239month-nearly-60-below-list-price
Amgen Launches AmgenNow Program, Offering ...
10/06/2025 13:08:09

Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire...

wall-street-hits-record-highs-as-rate-cut-bets-offset-shutdown-this-week-in-markets
Wall Street Hits Record Highs As Rate Cut ...
10/03/2025 20:15:46

S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easi...

pe-ratio-insights-for-amgen
P/E Ratio Insights for Amgen
10/03/2025 19:00:44

these-3-pharma-stocks-are-rallying--and-still-trade-absurdly-cheap
These 3 Pharma Stocks Are Rallying – And S...
10/02/2025 19:43:25

Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION